Browsing by Subject Drug Therapy, Combination
Showing results 1 to 3 of 3
| Publication Date | Title | Author(s) |
|---|---|---|
| 19-Nov-2020 | Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | Cavalcanti AB; Zampieri FG; Rosa RG; Azevedo LCP; Veiga VC; Avezum A; Damiani LP; Marcadenti A; Kawano-Dourado L; Lisboa T; Junqueira DLM; de Barros e Silva PGM; Tramujas L; Abreu-Silva EO; Laranjeira LN; Soares AT; Echenique LS; Pereira AJ; Freitas FGR; Gebara OCE; Dantas VCS; Furtado RHM; Milan EP; Golin NA; Cardoso FF; Maia IS; Hoffmann Filho CR; Kormann APM; Amazonas RB; Bocchi de Oliveira MF; Serpa-Neto A; Falavigna M; Lopes RD; Machado FR; Berwanger O |
| 2020 | Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) | McCullough PA; Alexander PE; Armstrong R; Arvinte C; Bain AF; Bartlett RP; Berkowitz RL; Berry AC; Borody TJ; Brewer JH; Brufsky AM; Clarke T; Derwand R; Eck A; Eck J; Eisner RA; Fareed GC; Farella A; Fonseca SNS; Geyer CE; Gonnering RS; Graves KE; Gross KBV; Hazan S; Held KS; Hight HT; Immanuel S; Jacobs MM; Ladapo JA; Lee LH; Littell J; Lozano I; Mangat HS; Marble B; McKinnon JE; Merritt LD; Orient JM; Oskoui R; Pompan DC; Procter BC; Prodromos C; Rajter JC; Rajter J-J; Ram CVS; Rios SS; Risch HA; Robb MJA; Rutherford M; Scholz M; Singleton MM; Tumlin JA; Tyson BM; Urso RG; Victory K; Vliet EL; Wax CM; Wolkoff AG; Wooll V; Zelenko V |
| Jul-2020 | Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018 | Coenen S; van der Velden AW; Cianci D; Goossens H; Bongard E; Saville BR; Gobat N; de Paor M; Ieven M; Verheij TJ; Butler CC |
